Ceva Santé Animale is a biotechnology and pharmaceutical company that has been innovating animal health and welfare since its establishment in 1989. The company focuses on researching, developing, producing, and marketing pharmaceutical products and vaccines for both companion and farm animals across the globe. Collaborating with small-scale livestock owners and veterinarians in Uganda to combat sleeping sickness and providing major animal welfare charities in the UK and USA with Adaptil® collars for rehoming shelter dogs, Ceva demonstrates a commitment to enhancing animal health and welfare in diverse environments and partnerships. The company's recent Venture Round investment in June 2020 was led by IDInvest Partners.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | Unknown | 1 | 01 Jun 2020 | |
Venture Round | Unknown | 9 | HOPU Investment Management Company, Continental Grain Company +1 | 04 Feb 2020 |
Debt Financing | Unknown | - | 01 May 2019 | |
Venture Round | Unknown | - | 28 Jul 2014 | |
Debt Financing | €100.00M | - | 30 Oct 2012 |
No recent news or press coverage available for Ceva Santé Animale.